Ads
related to: productive cough syrup in india list of drugs treatment
Search results
Results From The WOW.Com Content Network
Ambroxol is a drug that breaks up phlegm, used in the treatment of respiratory diseases associated with viscid or excessive mucus. Ambroxol is often administered as an active ingredient in cough syrup. It was patented in 1966 and came into medical use in 1979. [1]
Wockhardt is known for producing cough syrup with the sedative promethazine and the opiate codeine, used in the recreational street drug lean, which is sometimes referred to as "Wock", short for Wockhardt. [21]
It also includes drugs which are marketed as cough suppressants or antitussives, but their effectiveness in reducing cough symptoms is unclear or minimal. [ 1 ] [ 2 ] [ 3 ] While they have been used by 10% of American children in any given week, they are not recommended in Canada or the United States in children six years or younger because of ...
Codeine is also present in various cough syrups as codeine phosphate including chlorpheniramine maleate. Pure codeine is also available as codeine sulphate tablets. Codeine containing cough medicine has been banned in India with effect from 14 March 2016. The Ministry of Health and Family Welfare has found no proof of its efficacy against cough ...
The deaths of 12 children in northern India between December 2019 and January 2020, police allege, were caused by adulterated cough syrup made by drugmaker Digital Vision. Indian drugs regulators ...
Cough medicines usually contain mucoactive agents. Mucoactive agents are a class of chemical agents that aid in the clearance of mucus or sputum from the upper and lower airways, including the lungs, bronchi, and trachea. Mucoactive drugs include expectorants, mucolytics, mucoregulators, and mucokinetics.
NEW DELHI (Reuters) -India has found violations related to manufacturing and laboratory practices at drugmaker Riemann Labs, whose cough syrup was linked to the deaths of children in Cameroon, a ...
India's Uttar Pradesh state has permitted the resumption of most production at a factory owned by Marion Biotech, whose cough syrups Uzbekistan linked to the deaths of 65 children last year ...